Pet Vaccines Market Size, Share & Forecast 2025–2035 | Global Industry Report
Pet Vaccines Market Overview
According to MarketGenics,
the global Pet
Vaccines Market is projected to grow from USD 8.3 Billion in 2025
to approximately USD 19.1 Billion by 2035, registering a CAGR of 8.7%
during the forecast period (2025–2035). The market is experiencing steady
growth due to increasing pet ownership, rising awareness of preventive animal
healthcare, growing expenditure on companion animal health, and advancements in
veterinary vaccine technologies. The demand for effective vaccines against
infectious diseases in dogs, cats, and other companion animals continues to
increase as pet owners prioritize long-term health and wellness.
To obtain a free
sample research report - https://marketgenics.co/download-report-sample/pet-vaccines-market-94755?utm_source=Free&utm_medium=ruchika
Market Growth Drivers
- Rising global adoption of companion
animals, particularly dogs and cats.
- Increasing awareness regarding
preventive veterinary healthcare and routine immunization.
- Growing expenditure on pet healthcare
and veterinary services.
- Rising incidence of zoonotic and
infectious diseases affecting companion animals.
- Continuous advancements in recombinant,
DNA-based, and multivalent veterinary vaccines.
- Expansion of veterinary hospitals, pet
clinics, and animal diagnostic centers.
- Government initiatives and animal
welfare programs promoting vaccination.
Key Players
- Zoetis Inc.
- Merck Animal Health
- Boehringer Ingelheim Animal Health
- Elanco Animal Health
- Virbac
- Ceva Santé Animale
- HIPRA
- Biogenesis Bago
- Phibro Animal Health Corporation
- Vetoquinol
- Indian Immunologicals Limited
- Neogen Corporation
Regional Insights
North America
North America
dominates the Pet Vaccines Market due to high pet ownership rates,
well-established veterinary healthcare infrastructure, increasing pet insurance
coverage, and strong awareness regarding preventive animal healthcare.
Europe
Europe represents a
significant market driven by stringent animal health regulations, increasing
pet adoption, advanced veterinary services, and growing spending on companion
animal healthcare.
Asia-Pacific
Asia-Pacific is
expected to witness the fastest growth during the forecast period owing to
rising disposable incomes, increasing urban pet ownership, expanding veterinary
healthcare infrastructure, and growing awareness of preventive vaccination in
countries such as China, India, Japan, South Korea, and Australia.
Latin America, Middle East & Africa
These regions are
experiencing steady market growth due to improving veterinary healthcare
services, increasing awareness of animal welfare, and expanding pet care
industries.
Future Outlook
The Pet Vaccines
Market is expected to witness robust growth through 2035, driven by innovations
in recombinant vaccines, mRNA-based veterinary vaccines, and next-generation
immunization technologies. Increasing investments in veterinary research,
expanding pet insurance coverage, and growing demand for personalized animal
healthcare are expected to support long-term market expansion. Furthermore, the
integration of digital veterinary platforms, telehealth services, and
AI-assisted animal diagnostics is likely to enhance preventive healthcare and
improve vaccination compliance across global markets.
Related Reports:

Comments
Post a Comment